{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:00:15Z","timestamp":1787724015483,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA009599"],"award-info":[{"award-number":["T32CA009599"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1245\/s10434-022-12359-6","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T19:57:58Z","timestamp":1662753478000},"page":"480-489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Re-excision After Unplanned Excision of Soft Tissue Sarcoma is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease"],"prefix":"10.1245","volume":"30","author":[{"given":"Raymond S.","family":"Traweek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison N.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita F.","family":"Rajkot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Ashleigh","family":"Guadagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Z.","family":"Keung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keila E.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly K.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry W.","family":"Feig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.","family":"Roland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Scally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,9]]},"reference":[{"key":"12359_CR1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3322\/canjclin.54.2.94","volume":"54","author":"JN Cormier","year":"2004","unstructured":"Cormier JN, Pollock RE. Soft tissue sarcomas. CA Cancer J Clin. 2004;54:94\u2013109.","journal-title":"CA Cancer J Clin."},{"key":"12359_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13569-019-0115-4","volume":"9","author":"B Kasper","year":"2019","unstructured":"Kasper B. The challenge of finding new therapeutic avenues in soft tissue sarcomas. Clin Sarcoma Res. 2019;9:5.","journal-title":"Clin Sarcoma Res."},{"key":"12359_CR3","volume-title":"Tumours of soft tissue and bone: pathology and genetics: World Health Organization classification of tumours","author":"CDM Fletcher","year":"2013","unstructured":"Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F. Tumours of soft tissue and bone: pathology and genetics: World Health Organization classification of tumours. Lyon: IARC Press; 2013."},{"key":"12359_CR4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.2106\/00004623-199605000-00003","volume":"78","author":"S Noria","year":"1996","unstructured":"Noria S, et al. Residual disease following unplanned excision of soft-tissue sarcoma of an extremity. J Bone Joint Surg Am. 1996;78:650\u20135.","journal-title":"J Bone Joint Surg Am."},{"key":"12359_CR5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ciresp.2019.10.007","volume":"98","author":"PM Munoz","year":"2020","unstructured":"Munoz PM, et al. Impact of unplanned resection and re-excision of a soft tissue sarcoma on prognosis. Cir Esp Engl Ed. 2020;98:281\u20137.","journal-title":"Cir Esp Engl Ed."},{"key":"12359_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3928\/01477447-20210104-05","volume":"44","author":"P Gagnet","year":"2021","unstructured":"Gagnet P, et al. Analysis of the effect of the size and grade of soft tissue sarcoma on rates of unplanned resection, metastatic disease, mortality, and morbid re-resection over 20 years. Orthopedics. 2021;44:166\u201371.","journal-title":"Orthopedics."},{"key":"12359_CR7","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1245\/s10434-020-09564-6","volume":"28","author":"M Danieli","year":"2021","unstructured":"Danieli M, et al. Unplanned excision of extremity and trunk wall soft tissue sarcoma: to re-resect of not to re-resect? Ann Surg Oncol. 2021;28:4706\u201317.","journal-title":"Ann Surg Oncol."},{"key":"12359_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.617590","volume":"10","author":"Y Liang","year":"2021","unstructured":"Liang Y, et al. The impact of unplanned excision on the outcomes of patients with soft tissue sarcoma of the trunk and extremity: a propensity score-matching analysis. Front Oncol. 2021;10:617590.","journal-title":"Front Oncol"},{"key":"12359_CR9","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1245\/s10434-017-5776-8","volume":"24","author":"MA Smolle","year":"2017","unstructured":"Smolle MA, et al. The prognostic impact of unplanned excisions in a cohort of 728 soft tissue sarcoma patients: a multicentre study. Ann Surg Oncol. 2017;24:1596\u2013605.","journal-title":"Ann Surg Oncol."},{"key":"12359_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.5435\/JAAOS-D-15-00074","volume":"24","author":"NS Tedesco","year":"2016","unstructured":"Tedesco NS, Henshaw RM. Unplanned resection of sarcoma. J Am Acad Orthop Surg. 2016;24:150\u20139.","journal-title":"J Am Acad Orthop Surg."},{"key":"12359_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1302\/0301-620X.90B2.19760","volume":"90","author":"CR Chandrasekar","year":"2008","unstructured":"Chandrasekar CR, et al. The effect of an unplanned excision of a soft-tissue sarcoma on prognosis. J Bone Joint Surg Br. 2008;90:203\u20138.","journal-title":"J Bone Joint Surg Br."},{"key":"12359_CR12","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/jso.23021","volume":"105","author":"VK Alamanda","year":"2012","unstructured":"Alamanda VK, et al. Primary excision compared with re-excision of extremity soft tissue sarcoma: is anything new? J Surg Oncol. 2012;105:662\u20137.","journal-title":"J Surg Oncol."},{"key":"12359_CR13","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/cam4.615","volume":"5","author":"C Charoenlap","year":"2016","unstructured":"Charoenlap C, et al. Outcomes of unplanned sarcoma excision: impact of residual disease. Cancer Med. 2016;5:980\u20138.","journal-title":"Cancer Med."},{"key":"12359_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.suronc.2020.04.026","volume":"34","author":"G Scoccianti","year":"2020","unstructured":"Scoccianti G, et al. Re-excision after unplanned excision of soft tissue sarcomas: long-term results. Surg Oncol. 2020;34:212\u20137.","journal-title":"Surg Oncol."},{"key":"12359_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1245\/ASO.2006.03.030","volume":"13","author":"M Fiore","year":"2006","unstructured":"Fiore M, et al. Prognostic effect of re-excision in adult soft tissue sarcoma of the extremity. Ann Surg Oncol. 2006;13:110\u20137.","journal-title":"Ann Surg Oncol."},{"key":"12359_CR16","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1002\/cncr.31699","volume":"124","author":"EZ Keung","year":"2018","unstructured":"Keung EZ, et al. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer. 2018;124:4495\u2013503.","journal-title":"Cancer."},{"key":"12359_CR17","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/jso.24710","volume":"116","author":"MJ Maurice","year":"2017","unstructured":"Maurice MJ, et al. Predictors of surgical quality for retroperitoneal sarcoma: volume matters. J Surg Oncol. 2017;116:766\u201374.","journal-title":"J Surg Oncol."},{"key":"12359_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11864-020-0703-9","volume":"21","author":"EJ Brinkmann","year":"2020","unstructured":"Brinkmann EJ, Ahmed SK, Houdek MT. Extremity soft tissue sarcoma: role of local control. Curr Treat Options Oncol. 2020;21:13.","journal-title":"Curr. Treat. Options Oncol."},{"key":"12359_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.prro.2021.04.005","volume":"11","author":"KE Salerno","year":"2021","unstructured":"Salerno KE, et al. Radiation therapy for treatment of soft tissue sarcoma in adults: executive summary of an ASTRO clinical practice guideline. Pract Radiat Oncol. 2021;11:339\u201351.","journal-title":"Pract Radiat Oncol."},{"key":"12359_CR20","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1245\/s10434-019-07494-6","volume":"26","author":"G Decanter","year":"2019","unstructured":"Decanter G, et al. Watch and wait approach for re-excision after unplanned yet macroscopically complete excision of extremity and superficial truncal soft tissue sarcoma is safe and does not affect metastatic risk or amputation rate. Ann Surg Oncol. 2019;26:3526\u201334.","journal-title":"Ann Surg Oncol."},{"key":"12359_CR21","unstructured":"Guadagnolo BA, et al. Shorter course, hypofractionated pre-surgery radiation therapy in treating patients with localized, resectable soft tissue sarcoma of the extremity of superficial trunk. 2019 -. Identifier NCT03819985. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03819985."},{"key":"12359_CR22","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/S0140-6736(02)09292-9","volume":"359","author":"B O\u2019Sullivan","year":"2002","unstructured":"O\u2019Sullivan B, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomized trial. Lancet. 2002;359:2235\u201341.","journal-title":"Lancet."},{"issue":"3S Suppl 2","key":"12359_CR23","doi-asserted-by":"publisher","first-page":"S336","DOI":"10.1097\/SAP.0000000000002592","volume":"86","author":"DP Perrault","year":"2021","unstructured":"Perrault DP, et al. Risk factors for wound complications after soft tissue sarcoma resection. Ann Plast Surg. 2021;86(3S Suppl 2):S336\u201341.","journal-title":"Ann Plast Surg."},{"key":"12359_CR24","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1200\/JCO.2014.58.5828","volume":"33","author":"D Wang","year":"2015","unstructured":"Wang D, et al. Significant reduction of late toxicities in patients with extremity sarcoma treated with image-guided radiation therapy to a reduced target volume: results of radiation therapy oncology group RTOG-0630 trial. J Clin Oncol. 2015;33:2231\u20138.","journal-title":"J Clin Oncol."},{"key":"12359_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jss.2016.08.096","volume":"208","author":"AA Gingrich","year":"2017","unstructured":"Gingrich AA, et al. Predictors of residual disease after unplanned excision of soft tissue sarcomas. J Surg Res. 2017;208:26\u201332.","journal-title":"J Surg Res."},{"key":"12359_CR26","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1200\/JCO.1996.14.3.859","volume":"14","author":"PW Pisters","year":"1996","unstructured":"Pisters PW, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996;14:859\u201368.","journal-title":"J Clin Oncol."},{"key":"12359_CR27","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1200\/JCO.2008.16.6249","volume":"26","author":"KM Alektiar","year":"2008","unstructured":"Alektiar KM, et al. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity. J Clin Oncol. 2008;26:3440\u20134.","journal-title":"J Clin Oncol."},{"key":"12359_CR28","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/jso.25905","volume":"121","author":"RD Shelby","year":"2020","unstructured":"Shelby RD, et al. Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survival. J Surg Oncol. 2020;121:1249\u201358.","journal-title":"J Surg Oncol."},{"key":"12359_CR29","doi-asserted-by":"crossref","unstructured":"von Mehren M, et al. Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2018;16:536\u201363.","DOI":"10.6004\/jnccn.2018.0025"},{"key":"12359_CR30","unstructured":"Casali PG, et al; ESMO Guidelines Committee and EURACAN: soft tissue and visceral sarcomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv268\u20139."},{"key":"12359_CR31","doi-asserted-by":"crossref","unstructured":"Pisters PW, et al. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg. 2007;246:675\u201381; discussion 681\u20132.","DOI":"10.1097\/SLA.0b013e318155a9ae"},{"key":"12359_CR32","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/annonc\/mdt577","volume":"25","author":"M Toulmonde","year":"2014","unstructured":"Toulmonde M, et al. French Sarcoma Group: retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol. 2014;25:735\u201342.","journal-title":"Ann Oncol."},{"key":"12359_CR33","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3109\/0284186X.2012.711953","volume":"52","author":"VK Alamanda","year":"2013","unstructured":"Alamanda VK, et al. Predictors and clinical significance of local recurrence in extremity soft tissue sarcoma. Acta Oncol. 2013;52:793\u2013802.","journal-title":"Acta Oncol."},{"key":"12359_CR34","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1002\/cncr.32386","volume":"125","author":"M Chowdhary","year":"2019","unstructured":"Chowdhary M, et al. Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high-risk extremity\/trunk soft-tissue sarcoma? Cancer. 2019;125:3801\u20139.","journal-title":"Cancer."},{"key":"12359_CR35","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.3390\/cancers12092389","volume":"12","author":"DS Graham","year":"2020","unstructured":"Graham DS, et al. Chemotherapy and survival in patients with primary high-grade extremity and trunk soft tissue sarcoma. Cancers. 2020;12:2389.","journal-title":"Cancers."},{"key":"12359_CR36","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1186\/s12885-018-4829-0","volume":"18","author":"EZ Keung","year":"2018","unstructured":"Keung EZ, et al. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer. 2018;18:913.","journal-title":"BMC Cancer."},{"key":"12359_CR37","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1158\/1078-0432.CCR-19-3524","volume":"26","author":"A Kalbasi","year":"2020","unstructured":"Kalbasi A, et al. A phase II trial of 5-day neoadjuvant radiotherapy for patients with high-risk primary soft tissue sarcoma. Clin Cancer Res. 2020;26:1829\u201336.","journal-title":"Clin Cancer Res."},{"key":"12359_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.suronc.2019.04.004","volume":"29","author":"M Vos","year":"2019","unstructured":"Vos M, et al. Natural history of well-differentiated liposarcoma of the extremity compared to patients treated with surgery. Surg Oncol. 2019;29:84\u20139.","journal-title":"Surg Oncol."},{"key":"12359_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/jso.26246","volume":"123","author":"D Callegaro","year":"2021","unstructured":"Callegaro D, et al. Strategies for care of patients with gastrointestinal stromal tumor or soft tissue sarcoma during COVID-19 pandemic: a guide for surgical oncologists. J Surg Oncol. 2021;123:12\u201323.","journal-title":"J Surg Oncol."},{"key":"12359_CR40","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1002\/cncr.11367","volume":"97","author":"GK Zagars","year":"2003","unstructured":"Zagars GK, et al. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy. Cancer. 2003;97:2544\u201353.","journal-title":"Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12359-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12359-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12359-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T17:21:30Z","timestamp":1670347290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12359-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["12359"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12359-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,9]]},"assertion":[{"value":"28 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Kelly Hunt Armada Health\u2013Medical Advisory Board, AstraZeneca\u2013Medical Advisory Board, Research funding to my institution\u2014- Cairn Surgical, Eli Lilly & Co., Lumicell Christina Roland Bristol Myers Squibb-research funding.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}